Population Heterogeneity and Selection of Coronary Artery Disease Polygenic Scores

Carla Debernardi1, Angelo Savoca1, Alessandro De Gregorio1

  • 1Genomic Variation, Complex Diseases and Population Medicine Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

PubMed

Insights

Selecting the right polygenic score (PGS) for coronary artery disease (CAD) is crucial. This study found PGS003727 performed best in the Italian population, highlighting the need for population-specific evaluations of genetic risk scores.

Area of Science:

  • Genetics
  • Cardiology
  • Population Health

Background:

  • Identifying individuals at high risk for coronary artery disease (CAD) is essential for timely clinical intervention.
  • Numerous polygenic scores (PGSs) exist to estimate genetic risk for CAD.
  • Existing PGSs often lack representation from diverse populations, necessitating evaluation in specific ethnic groups like the Italian population.

Purpose of the Study:

  • To evaluate the performance of various polygenic scores (PGSs) for coronary artery disease (CAD) risk prediction in the Italian population.
  • To identify the most accurate PGS for CAD in Italians.
  • To assess the impact of incorporating conventional CAD risk factors on PGS performance.

Main Methods:

  • Utilized two independent Italian cohorts: EPICOR (576 individuals) and ATVB (3359 individuals).
  • Evaluated 266 cardiovascular disease risk PGSs from the PGS Catalog, narrowing down to 51 for CAD.
  • Assessed PGS performance using area under the curve (AUC) and analyzed the effect of adding traditional risk factors.

Main Results:

  • Significant differences in distributions between patients and controls were observed for 49 out of 51 evaluated PGSs (p < 0.01).
  • Only five PGSs were specifically trained and tested on European populations.
  • PGS003727 showed the highest accuracy in independent evaluations (EPICOR AUC = 0.68; ATVB AUC = 0.80).
  • Integration of conventional CAD risk factors improved model performance, especially in the ATVB cohort (p = 0.0003).

Conclusions:

  • European-derived CAD PGSs may yield varying risk estimates in distinct populations, such as the Italian population.
  • Geographical and ethnic variations necessitate careful consideration when applying PGSs.
  • Further validation studies are recommended to ensure the clinical applicability of CAD PGSs across diverse populations.
Abstract

Related Concept Videos

Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
64.9K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.6K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heritability01:06

Heritability

Heritability is a statistical concept that measures the degree to which genetic differences among individuals contribute to trait variations within a population. It is a fundamental idea in genetics, often prone to misinterpretation. Heritability is expressed as a percentage, reflecting the proportion of variation in a specific trait across a population that can be linked to genetic differences. However, it's important to understand that heritability does not determine how "genetic"...
192